Eating smaller, protein-rich meals more frequently can actually reduce nausea compared to eating larger, carb-heavy meals less often
Conclusion Both Semaglutide and Tirzepatide represent significant advancements in the treatment of type 2 diabetes, offering effective glycemic control and weight management benefits
First, the insulinotropic actions of tirzepatide in human islets are dependent upon GIPR activity
As the active ingredient in Mounjaro (approved May 2022 for type 2 diabetes) and Zepbound (approved November 2023 for chronic weight management, expanded December 2024 for obstructive sleep apnea), tirzepatide works by mimicking two natural hormones GLP-1 and GIP that regulate hunger, blood sugar, and metabolism
Retrieved from Eli Lilly-d
This is the second tirzepatide dosing tier in standard titration protocols, typically reached after four weeks at 2.5 mg